![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 53, Issue 1, 123-127, January 1998
Institut für Pharmakologie, Freie Universität Berlin,
Thielallee 69-73, D-14195 Berlin, Germany
The signaling molecule nitric oxide (NO) mediates many of its effects
by the stimulation of soluble guanylyl cyclase (sGC). The activation
process is initiated by high-affinity binding of NO to the enzyme's
prosthetic heme group. Despite its poor sGC-activating properties,
carbon monoxide (CO) has also been suggested as a physiological
activator of sGC. Recently, we have shown that the substance YC-1, a
benzyl indazole derivative, stimulates sGC by 10-fold (independently of
NO) potentiates the stimulatory effect of NO, and turns CO into a
potent activator of sGC. In the present study, we show that activation
of sGC by protoporphyrin IX, a ligand-independent activator, was
potentiated by YC-1, yet a shift of the concentration-response curve as
seen with NO and CO was not observed. YC-1 slowed down the dissociation
rates for NO and CO from the activated enzyme as monitored by cGMP
accumulation after addition of the NO and CO scavenger oxyhemoglobin. A
direct interaction of YC-1 with the heme group can be ruled out because YC-1 did not change the Soret absorption of basal or stimulated sGC
and, in addition, still bound to the heme-depleted enzyme. Together,
our results indicate that YC-1 increases the maximal catalytic rate and
sensitizes the enzyme toward its gaseous activators by binding to an
allosteric site on sGC molecules, thereby reducing the ligand
dissociation rate from the heme group.
This article has been cited by other articles:
|
|
 |
|
  X. Hu, L. B. Murata, A. Weichsel, J. L. Brailey, S. A. Roberts, A. Nighorn, and W. R. Montfort Allostery in Recombinant Soluble Guanylyl Cyclase from Manduca sexta J. Biol. Chem., July 25, 2008; 283(30): 20968 - 20977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Roy, E. J. Halvey, and J. Garthwaite An Enzyme-linked Receptor Mechanism for Nitric Oxide-activated Guanylyl Cyclase J. Biol. Chem., July 4, 2008; 283(27): 18841 - 18851. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Abraham and A. Kappas Pharmacological and Clinical Aspects of Heme Oxygenase Pharmacol. Rev., March 1, 2008; 60(1): 79 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Winger, E. R. Derbyshire, and M. A. Marletta Dissociation of Nitric Oxide from Soluble Guanylate Cyclase and Heme-Nitric Oxide/Oxygen Binding Domain Constructs J. Biol. Chem., January 12, 2007; 282(2): 897 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Duranski, J. W. Elrod, J. W. Calvert, N. S. Bryan, M. Feelisch, and D. J. Lefer Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2980 - H2986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Garthwaite, K. Bartus, D. Malcolm, D. Goodwin, M. Kollb-Sielecka, C. Dooldeniya, and J. Garthwaite Signaling from blood vessels to CNS axons through nitric oxide. J. Neurosci., July 19, 2006; 26(29): 7730 - 7740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chlopicki, R. Olszanecki, E. Marcinkiewicz, M. Lomnicka, and R. Motterlini Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase Cardiovasc Res, July 15, 2006; 71(2): 393 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-J. Yeo, J.-H. Ryu, Y.-S. Chun, Y.-S. Cho, I.-J. Jang, H. Cho, J. Kim, M.-S. Kim, and J.-W. Park YC-1 Induces S Cell Cycle Arrest and Apoptosis by Activating Checkpoint Kinases. Cancer Res., June 15, 2006; 66(12): 6345 - 6352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schindler, H. Strobel, K. Schonafinger, W. Linz, M. Lohn, P. A. Martorana, H. Rutten, P. W. Schindler, A. E. Busch, M. Sohn, et al. Biochemistry and Pharmacology of Novel Anthranilic Acid Derivatives Activating Heme-Oxidized Soluble Guanylyl Cyclase Mol. Pharmacol., April 1, 2006; 69(4): 1260 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gocmen, H. S. Buyuknacar, A. Y. Kots, F. Murad, O. Kiroglu, and E. K. Kumcu The Relaxant Activity of 4,7-Dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-Trioxide in the Mouse Corpus Cavernosum J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 753 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dumitrascu, N. Weissmann, H. A. Ghofrani, E. Dony, K. Beuerlein, H. Schmidt, J.-P. Stasch, M. J. Gnoth, W. Seeger, F. Grimminger, et al. Activation of Soluble Guanylate Cyclase Reverses Experimental Pulmonary Hypertension and Vascular Remodeling Circulation, January 17, 2006; 113(2): 286 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Linder, L. P. McCluskey, K. R. Cole III, K. M. Lanning, and R. C. Webb Dynamic Association of Nitric Oxide Downstream Signaling Molecules with Endothelial Caveolin-1 in Rat Aorta J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 9 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zhang, A. Beuve, and E. Townes-Anderson The Nitric Oxide-cGMP Signaling Pathway Differentially Regulates Presynaptic Structural Plasticity in Cone and Rod Cells J. Neurosci., March 9, 2005; 25(10): 2761 - 2770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Balashova, F.-J. Chang, M. Lamothe, Q. Sun, and A. Beuve Characterization of a Novel Type of Endogenous Activator of Soluble Guanylyl Cyclase J. Biol. Chem., January 21, 2005; 280(3): 2186 - 2196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Langlais, J. A. Stewart, and D. B. Morton Preliminary characterization of two atypical soluble guanylyl cyclases in the central and peripheral nervous system of Drosophila melanogaster J. Exp. Biol., June 1, 2004; 207(13): 2323 - 2338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Schmidt, M. Schramm, H. Schroder, F. Wunder, and J.-P. Stasch Identification of Residues Crucially Involved in the Binding of the Heme Moiety of Soluble Guanylate Cyclase J. Biol. Chem., January 23, 2004; 279(4): 3025 - 3032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Martin, I. Sharina, A. Kots, and F. Murad A constitutively activated mutant of human soluble guanylyl cyclase (sGC): Implication for the mechanism of sGC activation PNAS, August 5, 2003; 100(16): 9208 - 9213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Grosser and H. Schroder Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP Pathway Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1345 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Friebe and D. Koesling Regulation of Nitric Oxide-Sensitive Guanylyl Cyclase Circ. Res., July 25, 2003; 93(2): 96 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koglin and S. Behrends A Functional Domain of the alpha 1 Subunit of Soluble Guanylyl Cyclase Is Necessary for Activation of the Enzyme by Nitric Oxide and YC-1 but Is Not Involved in Heme Binding J. Biol. Chem., March 28, 2003; 278(14): 12590 - 12597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Behrends, A. Mietens, J. Kempfert, M. Koglin, H. Scholz, and R. Middendorff The Expression Pattern of Nitric Oxide-sensitive Guanylyl Cyclase in the Rat Heart Changes During Postnatal Development J. Histochem. Cytochem., October 1, 2002; 50(10): 1325 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Russwurm, E. Mergia, F. Mullershausen, and D. Koesling Inhibition of Deactivation of NO-sensitive Guanylyl Cyclase Accounts for the Sensitizing Effect of YC-1 J. Biol. Chem., July 5, 2002; 277(28): 24883 - 24888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Garthwaite, D. A. Goodwin, S. Neale, D. Riddall, and J. Garthwaite Soluble Guanylyl Cyclase Activator YC-1 Protects White Matter Axons from Nitric Oxide Toxicity and Metabolic Stress, Probably through Na+ Channel Inhibition Mol. Pharmacol., January 1, 2002; 61(1): 97 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Martin, Y.-C. Lee, and F. Murad YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components PNAS, October 25, 2001; (2001) 231486198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-E. Andersson Pharmacology of Penile Erection Pharmacol. Rev., September 1, 2001; 53(3): 417 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schmidt, A. Schrammel, D. Koesling, and B. Mayer Molecular Mechanisms Involved in the Synergistic Activation of Soluble Guanylyl Cyclase by YC-1 and Nitric Oxide in Endothelial Cells Mol. Pharmacol., February 1, 2001; 59(2): 220 - 224. [Abstract] [Full Text]
|
|
|
|
|
|
B. Tantini, F. Flamigni, C. Pignatti, C. Stefanelli, M. Fattori, A. Facchini, E. Giordano, C. Clo, and C. M. Caldarera Polyamines, NO and cGMP mediate stimulation of DNA synthesis by tumor necrosis factor and lipopolysaccharide in chick embryo cardiomyocytes Cardiovasc Res, February 1, 2001; 49(2): 408 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Lee, E. Martin, and F. Murad Human recombinant soluble guanylyl cyclase: Expression, purification, and regulation PNAS, September 19, 2000; (2000) 190333697. [Abstract] [Full Text]
|
|
|
|
|
|
T. C. Bellamy, J. Wood, D. A. Goodwin, and J. Garthwaite Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses PNAS, March 14, 2000; 97(6): 2928 - 2933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Taimor, B. Hofstaetter, and H.M. Piper Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia Cardiovasc Res, February 1, 2000; 45(3): 588 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Friebe, F. Müllershausen, A. Smolenski, U. Walter, G. Schultz, and D. Koesling YC-1 Potentiates Nitric Oxide- and Carbon Monoxide-Induced Cyclic GMP Effects in Human Platelets Mol. Pharmacol., December 1, 1998; 54(6): 962 - 967. [Abstract] [Full Text]
|
|
|
|
|
|
Y.-C. Lee, E. Martin, and F. Murad Human recombinant soluble guanylyl cyclase: Expression, purification, and regulation PNAS, September 26, 2000; 97(20): 10763 - 10768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Martin, Y.-C. Lee, and F. Murad YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components PNAS, November 6, 2001; 98(23): 12938 - 12942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Laber, T. Kober, V. Schmitz, A. Schrammel, W. Meyer, B. Mayer, M. Weber, and G. Kojda Effect of Hypercholesterolemia on Expression and Function of Vascular Soluble Guanylyl Cyclase Circulation, February 19, 2002; 105(7): 855 - 860. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
